William C Bertrand JR Insider Trading
Get free email notifications about insider trading for William C Bertrand JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William C Bertrand JR. William C Bertrand JR is a Senior VP, General Counsel in MEDIMMUNE INC /DE ($MEDI) and a Sr.VP, Gen Counsel & Secretary in MEDIMMUNE INC /DE ($MEDI) and a SVP, General Counsel in MEDIMMUNE INC /DE ($MEDI) and a SVP, General Counsel, Sec in MEDIMMUNE INC /DE ($MEDI) and a VP, Gen Counsel & Secretary in MEDIMMUNE INC /DE ($MEDI) and a See Remarks in SALIX PHARMACEUTICALS LTD ($SLXP) and a General Counsel in INFINITY PHARMACEUTICALS, INC. ($INFI) and a Director in ARDELYX, INC. ($ARDX) and a Chief Operating Officer in Adaptimmune Therapeutics PLC ($ADAP).
Address: ONE MEDIMMUNE WAY GAITHERSBURG 20878 MD
Companies in which William C Bertrand JR is an Insider
Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of William C Bertrand JR: Chief Operating Officer
Holdings: 3,768 shares
Current Value: $17,069
Latest Transaction: Jan 12 2021
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARDELYX, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William C Bertrand JR: Director
Holdings: 74,658 shares
Current Value: $824,971
Latest Transaction: Dec 15 2020
$ARDX Market Capitalization: $529.77M
$ARDX Previous Close: $11.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INFINITY PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William C Bertrand JR: General Counsel
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 21 2015
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDIMMUNE INC /DE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of William C Bertrand JR: SVP, General Counsel, Sec, Senior VP, General Counsel, SVP, General Counsel, Sr.VP, Gen Counsel & Secretary, VP, Gen Counsel & Secretary
Holdings: 0 shares
Latest Transaction: Jun 19 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SALIX PHARMACEUTICALS LTD
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William C Bertrand JR: See Remarks
Holdings: 0 shares
Latest Transaction: Apr 03 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of William C Bertrand JR
Sentiment: All, ADAP, ARDX, INFI, MEDI, SLXP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Sell | S | 6.15 | 2,234 | 13,744 | 3,768 | 6 K to 3.8 K (-37.22 %) |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Option Exercise | A | 0.00 | 242,712 | 340 | 242,712 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Option Exercise | A | 1.03 | 1,086,816 | 1,119,420 | 1,086,816 | |
| Jan 05 2021 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Sell | S | 5.33 | 3,499 | 18,642 | 5,864 | 9.4 K to 5.9 K (-37.37 %) |
| Dec 15 2020 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Buy | P | 0.69 | 207,000 | 143,824 | 284,808 | 77.8 K to 284.8 K (+266.04 %) |
| Dec 15 2020 | ARDX | ARDELYX, INC. | Bertrand William C JR | Director | Grant | A | 7.08 | 15,000 | 106,256 | 74,658 | 59.7 K to 74.7 K (+25.14 %) |
| Jun 11 2020 | ARDX | ARDELYX, INC. | Bertrand William C JR | Director | Option Exercise | A | 7.31 | 23,500 | 171,785 | 23,500 |